JAK3/BTK-IN-4 is a potent JAK3/BTK inhibitor with potential for the study of JAK3 kinase- and/or BTK-related diseases; dual inhibition of BTK and JAK3 signaling pathways exhibits synergistic effects, making it a promising candidate for targeting autoimmune diseases.